| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Solid Tumors > Liver Tumors | ||||||
| DFCI 19-338 | NCT04134559 | Rangaswami, Arun | Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma | |||
| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Solid Tumors > Kidney Tumors | ||||||
| AREN1921 | NCT04322318 | Rangaswami, Arun | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | |||
| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Solid Tumors > Osteosarcoma | ||||||
| DFCI 20-086 | NCT04417062 | Vo, Kieuhoa | Olaparib With Ceralasertib in Recurrent Osteosarcoma | |||
| PED-CITN-03 | NCT04751383 | Vo, Kieuhoa | Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma | |||
| PEPN1924 | NCT04616560 | Vo, Kieuhoa | Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma | |||
| Protocol No. | ClinicalTrials.gov Protocol No. | PI Name | Title | |||
| Pediatric Cancers > Solid Tumors | ||||||
| ADVL1921 | NCT03709680 | Vo, Kieuhoa | Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors | |||
| APEC1621A | NCT03213704 | Rangaswami, Arun | Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) | |||
| APEC1621B | NCT03210714 | Rangaswami, Arun | Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) | |||
| APEC1621D | NCT03213678 | Rangaswami, Arun | Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) | |||
| APEC1621F | NCT03213652 | Rangaswami, Arun | Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) | |||
| APEC1621K | NCT04195555 | Rangaswami, Arun | Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) | |||
| APEC1621N | NCT04320888 | Rangaswami, Arun | Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial | |||
| APEC1621SC | NCT03155620 | Rangaswami, Arun | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | |||
| DFCI 15-169 | NCT02520713 | Sabnis, Amit | The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study | |||
| PEPN2011 | NCT04851119 | Vo, Kieuhoa | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors | |||
| PEPN2112 | NCT05071209 | Vo, Kieuhoa | Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors | |||
| ARST1921 | NCT04195399 | Rangaswami, Arun | A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery | |||